Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation.

Stewart RA.

Curr Opin Cardiol. 2011 Jul;26(4):294-9. doi: 10.1097/HCO.0b013e3283477dbc. Review.

PMID:
21537165
2.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
3.

Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.

Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):480-6. doi: 10.1161/CIRCOUTCOMES.112.965988. Epub 2012 Jul 10.

4.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
5.

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

Deedwania PC, Huang GW.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):265-75. doi: 10.2165/11592410-000000000-00000. Review.

PMID:
21740079
6.

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

Mantha S, Ansell J.

Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28. Review.

PMID:
22740145
7.

Prevention of stroke in patients with atrial fibrillation.

Olsson SB, Halperin JL.

Semin Vasc Med. 2005 Aug;5(3):285-92. Review.

PMID:
16123916
8.

Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.

Martí-Fàbregas J, Mateo J.

Cerebrovasc Dis. 2009;27 Suppl 1:111-9. doi: 10.1159/000200448. Epub 2009 Apr 3. Review.

PMID:
19342840
9.
10.
11.

New options for stroke prevention in atrial fibrillation.

Cannon CP, Stecker EC.

Am J Manag Care. 2010 Nov;16(10 Suppl):S291-7. Review.

12.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
13.

[Preventing cerebrovascular accidents during atrial fibrillation].

Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A.

Presse Med. 2005 Oct 22;34(18):1315-24. Review. French.

PMID:
16269996
14.

Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials.

Albers GW; SPORTIF Investigators.

Am J Manag Care. 2004 Dec;10(14 Suppl):S462-9; discussion S469-73. Review.

15.

Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.

Schirmer SH, Baumhäkel M, Neuberger HR, Hohnloser SH, van Gelder IC, Lip GY, Böhm M.

J Am Coll Cardiol. 2010 Dec 14;56(25):2067-76. doi: 10.1016/j.jacc.2010.09.017. Review.

16.
18.

Apixaban for the prevention of stroke in atrial fibrillation.

Littrell R, Flaker G.

Expert Rev Cardiovasc Ther. 2012 Feb;10(2):143-9. doi: 10.1586/erc.11.187. Review.

PMID:
22292869
19.

The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?

Diener HC, Eikelboom J, Granger CB, Hacke W.

Int J Stroke. 2012 Feb;7(2):139-41. doi: 10.1111/j.1747-4949.2011.00739.x.

PMID:
22264366
20.

Preventing stroke in atrial fibrillation: the SPORTIF programme.

Lip GY.

Pathophysiol Haemost Thromb. 2005;34 Suppl 1:25-30. Review.

PMID:
15812201
Items per page

Supplemental Content

Write to the Help Desk